Commissioner Dalli says imaging technologies are vital for personalised medicines

On 18 September 2012, members of the Policy Affairs Working Group attended an event hosted by the European Alliance for Personalised Medicines (EAPM).

Commissioner for Health and Consumers John Dalli, told participants of the importance of imaging technologies and in-vitro diagnostic medical devices (IVDs) to the development of personalized medicines.

Commissioner Dalli stressed that we can no longer be satisfied with finding out what kind of disease a patient has, we must find out what kind of patient is being affected by the disease. He also stressed that such imaging technologies are of key importance in the prevention of adverse reactions to medicines.

That Commissioner Dalli is linking an increasingly popular topic such as personalized medicines as dependant on imaging technologies is very positive to the goals of VPH.


Date: 18/09/2012 | Tag: | News: 76 of 576
All news

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

Are you...

A clinician?
A researcher?
A science curious?
An industrial?

Open subscribe

ARCHIVE

Read all the newsletters of the VPH Institute

GO